Psilocybin businesses are excluded from tax Added benefits made available to other enterprises—massive and smaller alike—as a consequence of US tax code 280E. The code prohibits primary deductions for those that interact with Schedule I and Agenda II managed substances. Provider centers are predicted to normally compensate for that by obtaining